OrsoBio, Inc.
Biotechnology company · Menlo Park, California, United States
OrsoBio, Inc. is a biotechnology company headquartered in Menlo Park, California, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2024.
OrsoBio at a glance
What does OrsoBio do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2022 to 2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $40 million sold (2024).
Frequently asked questions about OrsoBio
Where is OrsoBio headquartered?
OrsoBio, Inc. is headquartered in Menlo Park, California, United States.
What does OrsoBio do?
OrsoBio, Inc. is a biotechnology company.
When was OrsoBio founded?
The earliest incorporation on record for OrsoBio, Inc. is in 2020, according to public company registers.
Similar companies
- Phenomix Sciences, Inc.Menlo Park, California, United States
- Subtle Medical, Inc.Menlo Park, California, United States
- Photoswitch Biosciences, Inc.Menlo Park, California, United States
- Recode Therapeutics, Inc.Menlo Park, California, United States
- Medikine IncMenlo Park, California, United States
- ForSight VISION5, Inc.Menlo Park, California, United States
- Tusker Medical, Inc.Menlo Park, California, United States
- Recida Therapeutics, Inc.Menlo Park, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences